Advertisement

Journal of Applied Spectroscopy

, Volume 84, Issue 6, pp 1114–1123 | Cite as

Modified Extraction-Free Ion-Pair Methods for the Determination of Flunarizine Dihydrochloride in Bulk Drug, Tablets, and Human Urine

  • K. N. Prashanth
  • K. Basavaiah
Article
  • 14 Downloads

Two simple and sensitive extraction-free spectrophotometric methods are described for the determination of flunarizine dihydrochloride. The methods are based on the ion-pair complex formation between the nitrogenous compound flunarizine (FNZ), converted from flunarizine dihydrochloride (FNH), and the acidic dye phenol red (PR), in which experimental variables were circumvented. The first method (method A) is based on the formation of a yellow-colored ion-pair complex (1:1 drug:dye) between FNZ and PR in chloroform, which is measured at 415 nm. In the second method (method B), the formed drug-dye ion-pair complex is treated with ethanolic potassium hydroxide in an ethanolic medium, and the resulting base form of the dye is measured at 580 nm. The stoichiometry of the formed ion-pair complex between the drug and dye (1:1) is determined by Job's continuous variations method, and the stability constant of the complex is also calculated. These methods quantify FNZ over the concentration ranges 5.0–70.0 in method A and 0.5–7.0 μg/mL in method B. The calculated molar absorptivities are 6.17 × 103 and 5.5 × 104 L/mol·cm–1 for method A and method B, respectively, with corresponding Sandell sensitivity values of 0.0655 and 0.0074 μg/cm2. The methods are applied to the determination of FNZ in pure drug and human urine.

Keywords

extraction-free ion-pair complex phenol red flunarizine pharmaceutical formulation human urine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. A. Todd and P. Benfield, Drugs, 38, 481 (1989).CrossRefGoogle Scholar
  2. 2.
    M. R. Alan, D. S. Fred, and J. T. Stewart, Conquering Headache, 4th edn., Decker DTC, Hamilton, London (2003).Google Scholar
  3. 3.
    European Pharmacopoeia, Vol. II, European Department for the Quality of Medicines, Council of Europe, Stranbourg, France (2005).Google Scholar
  4. 4.
    British Pharmacopoeia, Vol. II, Her Majesty's Stationary Office, London (2009).Google Scholar
  5. 5.
    A. A. M. Wahbi, M. E. Abdel-Fattah, E. M. Hassan, F. G. Saliman, and El-Gendi, J. Pharm. Biomed. Anal., 13, 777 (1995).CrossRefGoogle Scholar
  6. 6.
    W. F. Kartinasari, H. Chufianty, and G. Indrayanto, J. Liq. Chromatogr. Related Technol., 26, 1059 (2003).CrossRefGoogle Scholar
  7. 7.
    S. P. Amod, A. A. Shirkhedkar, J. S. Surana, and S. P. Nawale, J. Chil. Chem. Soc., 57, 1033 (2012).CrossRefGoogle Scholar
  8. 8.
    M. Abdul-Azim Mohammad, Bull Fac. Pharm. Cairo Univ., 42, 27 (2004).Google Scholar
  9. 9.
    S. A. Patil, A. A. Shirkhedkar, J. S. Surana, and S. P. Nawale, Pharma Chem., 3, 404 (2011).Google Scholar
  10. 10.
    A. K. Doshi, B. N. Patel, and C. N. Patel, Int. J. Pharm. Sci. Res., 3, 1741 (2012).Google Scholar
  11. 11.
    K. Busaranon, W. Suntornsuk, and L. Suntornsuk, J. Pharm. Biomed. Anal., 41, 158 (2006).CrossRefGoogle Scholar
  12. 12.
    V. S. S. P. Adapa, C. Ravi, C. S. P. Sastry, and U. V. Prasad, Acta Cienc. Indica, Chem., 27, 105 (2001).Google Scholar
  13. 13.
    V. S. S. P. Adapa, C. S. R. Lakshmi, C. S. P. Sastry, and V. P. Uppuleti, J. Anal. Chem., 58, 937 (2003).CrossRefGoogle Scholar
  14. 14.
    M. Y. El-Maamli, Egypt. J. Biomed. Sci., 11, 122 (2003).Google Scholar
  15. 15.
    K. Kelani, I. L. Bebawy, and L. A. Fattah, J. Pharm. Biomed. Anal., 18, 985 (1999).CrossRefGoogle Scholar
  16. 16.
    M. J. Badalani, K. R. Mahadik, H. N. More, and S. S. Kadam, East Pharm., 38, 133 (1995).Google Scholar
  17. 17.
    M. S. Elazazy, M. El-Mammli, A. Shalaby, and M. A. Magda, Biosci., Biotechnol. Res. Asia, 5, 107 (2008).Google Scholar
  18. 18.
    V. S. S. P. Adapa, G. P. V. Mallikarjuna Rao, C. S. P. Sastry, and U. V. Prasad, J. Ind. Council Chem., 18, 36 (2001).Google Scholar
  19. 19.
    S. S. Zarapkar and R. K. Bapat, Indian Drugs, 31, 170 (1994).Google Scholar
  20. 20.
    V. S. S. P. Adapa and C. S. P. Sastry, Sci. Asia, 33, 119 (2007).CrossRefGoogle Scholar
  21. 21.
    A. F. M. E. Walily, A. E. Gindy, and A. A. M. Wahbi, J. Pharm. Biomed. Anal., 13, 53 (1995).CrossRefGoogle Scholar
  22. 22.
    K. N. Prashanth, K. Basavaiah, and M. S. Raghu, Chem. Sci. J., 80, 1–14 (2012).Google Scholar
  23. 23.
    K. N. Prashanth, K. Basavaiah, and K. B. Vinay, Arab. J. Chem. (2011); doi: https://doi.org/10.1016/j.arabjc.2011.10.006.
  24. 24.
    M. S. Raghu and K. Basavaiah, Proc. Natl. Acad. Sci., India A: Phys. Sci., 82, 187 (2012).Google Scholar
  25. 25.
    K. B. Vinay, H. D. Revannasiddappa, N. Rajendraprasad, P. J. Ramesh, M. X. Cijo, and K. Basavaiah, Drug Test Anal., 4, 116 (2012).CrossRefGoogle Scholar
  26. 26.
    H. Zavis, D. Ludvik, K. Milan, S. Ladislaw, and V. Frantisck, Handbook of Organic Reagents in Inorganic Analysis, Chichester, A Division of John Wiley & Sons IC, New York, London, Sydney, Toronto (1976).Google Scholar
  27. 27.
    International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology, Q2 (R 1), Complementary Guideline on Methodology dated 06 November 1996, London, incorporated in November 2005.Google Scholar
  28. 28.
    J. Inczedy, T. Lengyel, and A. M. Ure, IUPAC Compendium of Analytical Nomenclature: Definitive Rules, Blackwell Science Inc., Boston (1998).Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of Mysore, ManasagangotriMysoreIndia

Personalised recommendations